NDC 55111-404 – Ranitidine
Ranitidine Hydrochloride 150 mg/1 · Tablet, Coated · Oral
Product NDC55111-404
Product details
- Brand name
- Ranitidine
- Generic name
- Ranitidine
- Labeler
- Dr. Reddy's Laboratories Limited
- Dosage form
- Tablet, Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA078192
- Marketed since
- December 2, 2009
- Listing expires
- December 31, 2026
- Pharmacologic class
- Histamine-2 Receptor Antagonist
Active ingredients
- Ranitidine Hydrochloride 150 mg/1
Package NDC codes (14)
| Package NDC | Description | Since |
|---|---|---|
| 55111-404-02 | 1 BOTTLE in 1 CARTON (55111-404-02) / 200 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-17 | 1 BLISTER PACK in 1 CARTON (55111-404-17) / 8 TABLET, COATED in 1 BLISTER PACK | Dec 2, 2009 |
| 55111-404-24 | 3 BLISTER PACK in 1 CARTON (55111-404-24) / 8 TABLET, COATED in 1 BLISTER PACK | Dec 2, 2009 |
| 55111-404-32 | 1 BOTTLE in 1 CARTON (55111-404-32) / 32 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-34 | 1 BOTTLE in 1 CARTON (55111-404-34) / 24 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-36 | 1 BOTTLE in 1 CARTON (55111-404-36) / 36 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-38 | 4 BLISTER PACK in 1 CARTON (55111-404-38) / 8 TABLET, COATED in 1 BLISTER PACK | Dec 2, 2009 |
| 55111-404-40 | 1 BOTTLE in 1 BOTTLE (55111-404-40) / 40 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-50 | 1 BOTTLE in 1 CARTON (55111-404-50) / 50 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-55 | 2 BOTTLE in 1 CARTON (55111-404-55) / 65 TABLET, COATED in 1 BOTTLE | Jan 5, 2010 |
| 55111-404-61 | 1 BOTTLE in 1 CARTON (55111-404-61) / 65 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-62 | 1 BOTTLE in 1 CARTON (55111-404-62) / 95 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-65 | 1 BOTTLE in 1 CARTON (55111-404-65) / 220 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
| 55111-404-90 | 2 BOTTLE in 1 CARTON (55111-404-90) / 95 TABLET, COATED in 1 BOTTLE | Dec 2, 2009 |
Recalls mentioning this NDC
- D-0182-2020 Nov 13, 2019 · Class II
CGMP Deviations: Presence of NDMA impurity detected in product.
Other Ranitidine products
- 27241-109 Ranitidine Hydrochloride 150 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-110 Ranitidine Hydrochloride 300 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 53746-253 Ranitidine Hydrochloride 150 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 53746-254 Ranitidine Hydrochloride 300 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 55111-131 Ranitidine Hydrochloride 75 mg/1 · Tablet · Dr. Reddy's Laboratories Limited
- 62207-773 Ranitidine Hydrochloride 150 mg/1 · Tablet · Granules India Ltd
- 62207-774 Ranitidine Hydrochloride 150 mg/1 · Tablet · Granules India Ltd
- 0121-0727 Ranitidine 15 mg/mL · Syrup · Pharmaceutical Associates, Inc.
- 0121-4727 Ranitidine 15 mg/mL · Syrup · Pharmaceutical Associates, Inc.
- 64980-636 Ranitidine Hydrochloride 150 mg/1 · Tablet · Rising Pharma Holdings, Inc.
- 64980-637 Ranitidine Hydrochloride 300 mg/1 · Tablet · Rising Pharma Holdings, Inc.